Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-12-12 Purchase | 2020-02-10 4:20 pm | Inhibitor Therapeutics Inc. | INTI | Watson W. Mark Director | 500 | $0.0619 | $31 | 1,054,100 (Direct) | View |
| 2019-12-02 Purchase | 2019-12-02 8:57 pm | Inhibitor Therapeutics Inc. | INTI | Hasara Garrison J. CFO and Treasurer | 13,500 | $0.07 | $945 | 3,972,544 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-11 Option Award | 2023-08-29 3:49 pm | N/A N/A | Inhibitor Therapeutics Inc. | INTI | OSMAN RONALD E Ronald E Osman Irrevocable Trust III Director 10% Owner | 25,000 | $0 | 23,514,985 (Direct) | View |
Ownership | 2023-08-29 2:42 pm | N/A N/A | Inhibitor Therapeutics Inc. | INTI | Ronald E Osman Irrevocable Trust III OSMAN RONALD E 10% Owner | 0 | $0 | 23,489,985 (Direct) | View |
Ownership | 2023-05-22 3:44 pm | N/A N/A | Inhibitor Therapeutics Inc. | INTI | TPB 2012 LLC Donovan James Joseph III 10% Owner | 0 | $0 | 28,266,750 (Indirect) | View |
| 2023-05-05 Other | 2023-05-17 7:46 pm | N/A N/A | Inhibitor Therapeutics Inc. | INTI | MCNULTY JAMES A See Remarks 10% Owner | 100,126,261 | $0 | 127,173,453 (Indirect) | View |
Ownership | 2023-05-17 7:10 pm | N/A N/A | Inhibitor Therapeutics Inc. | INTI | Black Robe Capital LLC MCNULTY JAMES A 10% Owner | 0 | $0 | 20,101,057 (Direct) | View |
| 2023-05-05 Other | 2023-05-17 7:09 pm | N/A N/A | Inhibitor Therapeutics Inc. | INTI | Yanez Michelle Director | 796,271 | $0 | 1,596,944 (Direct) | View |
Ownership | 2022-12-22 9:35 pm | N/A N/A | Inhibitor Therapeutics Inc. | INTI | SEARS SAMUEL P JR Director | 0 | $0 | 969,096 (Direct) | View |
Ownership | 2022-12-22 9:33 pm | N/A N/A | Inhibitor Therapeutics Inc. | INTI | Yanez Michelle Director | 0 | $0 | 4,402 (Direct) | View |
Ownership | 2022-12-22 9:33 pm | N/A N/A | Inhibitor Therapeutics Inc. | INTI | ODONNELL FRANCIS E JR See Remarks 10% Owner | 0 | $0 | 85,627,069 (Indirect) | View |
Ownership | 2022-12-22 9:31 pm | N/A N/A | Inhibitor Therapeutics Inc. | INTI | MCNULTY JAMES A See Remarks 10% Owner | 0 | $0 | 86,325,069 (Direct) | View |
| 2021-01-15 Other | 2021-01-19 1:50 pm | N/A N/A | Inhibitor Therapeutics Inc. | INTI | Mayne Pharma Ventures Pty Ltd Mayne Pharma International Pty Ltd Mayne Pharma Group Ltd 10% Owner | 2,240,488 | $0 | 206,323,715 (Direct) | View |
| 2020-12-22 Option Award | 2020-12-28 4:30 pm | 2020-12-22 2030-12-22 | Inhibitor Therapeutics Inc. | INTI | Hasara Garrison J. CFO and Treasurer | 125,000 | $0 | 125,000 (Direct) | View |
| 2020-12-22 Option Award | 2020-12-28 4:30 pm | 2020-12-22 2030-12-22 | Inhibitor Therapeutics Inc. | INTI | Watson W. Mark Director | 1,306,452 | $0 | 1,306,452 (Direct) | View |
| 2020-12-22 Option Award | 2020-12-28 4:30 pm | 2020-12-22 2030-12-22 | Inhibitor Therapeutics Inc. | INTI | Ono Richard Dana Director | 754,839 | $0 | 754,839 (Direct) | View |
| 2020-12-22 Option Award | 2020-12-28 4:30 pm | 2020-12-22 2030-12-22 | Inhibitor Therapeutics Inc. | INTI | Peattie Debra Director | 580,646 | $0 | 580,646 (Direct) | View |
| 2020-12-22 Option Award | 2020-12-28 4:30 pm | 2020-12-22 2030-12-22 | Inhibitor Therapeutics Inc. | INTI | VIRCA NICHOLAS J President and CEO | 125,000 | $0 | 125,000 (Direct) | View |
| 2020-12-22 Option Award | 2020-12-28 4:30 pm | 2020-12-22 2030-12-22 | Inhibitor Therapeutics Inc. | INTI | Martin Robert Daniel Director | 754,839 | $0 | 754,839 (Direct) | View |
| 2020-09-17 Option Award | 2020-09-21 6:42 pm | 2020-09-17 2030-09-17 | Inhibitor Therapeutics Inc. | INTI | VIRCA NICHOLAS J President and CEO | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-09-17 Option Award | 2020-09-21 6:39 pm | 2020-09-17 2030-09-17 | Inhibitor Therapeutics Inc. | INTI | Hasara Garrison J. CFO and Treasurer | 100,000 | $0 | 100,000 (Direct) | View |
| 2020-07-15 Other | 2020-07-20 9:56 pm | N/A N/A | Inhibitor Therapeutics Inc. | INTI | Mayne Pharma Ventures Pty Ltd Mayne Pharma International Pty Ltd Mayne Pharma Group Ltd 10% Owner | 3,189,688 | $0 | 205,032,427 (Direct) | View |
| 2020-03-20 Option Award | 2020-03-24 09:02 am | 2021-03-20 2030-03-20 | Inhibitor Therapeutics Inc. | INTI | Ono Richard Dana Director | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2020-03-20 Option Award | 2020-03-24 09:01 am | 2021-03-20 2030-03-20 | Inhibitor Therapeutics Inc. | INTI | Peattie Debra Director | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2020-03-20 Option Award | 2020-03-24 09:00 am | 2021-03-20 2030-03-20 | Inhibitor Therapeutics Inc. | INTI | Martin Robert Daniel Director | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2020-03-20 Option Award | 2020-03-24 09:00 am | 2021-03-20 2030-03-20 | Inhibitor Therapeutics Inc. | INTI | Watson W. Mark Director | 1,500,000 | $0 | 1,500,000 (Direct) | View |
| 2019-12-12 Option Award | 2019-12-16 4:32 pm | 2020-02-03 2029-12-12 | Inhibitor Therapeutics Inc. | INTI | Peattie Debra Director | 210,000 | $0 | 210,000 (Direct) | View |
| 2019-06-03 Option Award | 2019-06-10 6:27 pm | 2020-02-03 2029-06-03 | HedgePath Pharmaceuticals Inc. | HPPI | Watson W. Mark Director | 25,000 | $0 | 25,000 (Direct) | View |